SE501217C2 - Cellproliferationsmatris och användning därav - Google Patents

Cellproliferationsmatris och användning därav

Info

Publication number
SE501217C2
SE501217C2 SE9003887A SE9003887A SE501217C2 SE 501217 C2 SE501217 C2 SE 501217C2 SE 9003887 A SE9003887 A SE 9003887A SE 9003887 A SE9003887 A SE 9003887A SE 501217 C2 SE501217 C2 SE 501217C2
Authority
SE
Sweden
Prior art keywords
cell proliferation
weight
sodium hyaluronate
average molecular
molecular weight
Prior art date
Application number
SE9003887A
Other languages
English (en)
Swedish (sv)
Other versions
SE9003887L (sv
Inventor
Kerstin Brismar
Bertil Aaberg
Original Assignee
Skandigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skandigen Ab filed Critical Skandigen Ab
Priority to SE9003887A priority Critical patent/SE501217C2/sv
Priority to AU90409/91A priority patent/AU649092B2/en
Priority to CA002097181A priority patent/CA2097181A1/en
Priority to JP4500592A priority patent/JPH06503319A/ja
Priority to EP92900297A priority patent/EP0560845B1/en
Priority to PCT/SE1991/000839 priority patent/WO1992010195A1/en
Priority to US08/066,165 priority patent/US5432167A/en
Priority to AT92900297T priority patent/ATE157253T1/de
Priority to DE69127459T priority patent/DE69127459T2/de
Priority to KR1019930701656A priority patent/KR100206314B1/ko
Publication of SE9003887L publication Critical patent/SE9003887L/xx
Publication of SE501217C2 publication Critical patent/SE501217C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mattresses And Other Support Structures For Chairs And Beds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9003887A 1990-12-06 1990-12-06 Cellproliferationsmatris och användning därav SE501217C2 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9003887A SE501217C2 (sv) 1990-12-06 1990-12-06 Cellproliferationsmatris och användning därav
AU90409/91A AU649092B2 (en) 1990-12-06 1991-12-05 Cell proliferation matrix and use thereof
CA002097181A CA2097181A1 (en) 1990-12-06 1991-12-05 Cell proliferation matrix and use thereof
JP4500592A JPH06503319A (ja) 1990-12-06 1991-12-05 細胞増殖マトリックス及びその用法
EP92900297A EP0560845B1 (en) 1990-12-06 1991-12-05 Cell proliferation matrix and use thereof
PCT/SE1991/000839 WO1992010195A1 (en) 1990-12-06 1991-12-05 Cell proliferation matrix and use thereof
US08/066,165 US5432167A (en) 1990-12-06 1991-12-05 Cell proliferation matrix and use thereof
AT92900297T ATE157253T1 (de) 1990-12-06 1991-12-05 Zellprofilerationsmatritze und ihre verwendung
DE69127459T DE69127459T2 (de) 1990-12-06 1991-12-05 Zellprofilerationsmatritze und ihre verwendung
KR1019930701656A KR100206314B1 (ko) 1990-12-06 1991-12-05 세포증식 매트릭스

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003887A SE501217C2 (sv) 1990-12-06 1990-12-06 Cellproliferationsmatris och användning därav

Publications (2)

Publication Number Publication Date
SE9003887L SE9003887L (sv) 1992-06-07
SE501217C2 true SE501217C2 (sv) 1994-12-12

Family

ID=20381109

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003887A SE501217C2 (sv) 1990-12-06 1990-12-06 Cellproliferationsmatris och användning därav

Country Status (10)

Country Link
US (1) US5432167A (ko)
EP (1) EP0560845B1 (ko)
JP (1) JPH06503319A (ko)
KR (1) KR100206314B1 (ko)
AT (1) ATE157253T1 (ko)
AU (1) AU649092B2 (ko)
CA (1) CA2097181A1 (ko)
DE (1) DE69127459T2 (ko)
SE (1) SE501217C2 (ko)
WO (1) WO1992010195A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2721303C1 (ru) * 2019-12-03 2020-05-18 Самсунг Электроникс Ко., Лтд. Оптически-управляемый переключатель миллиметрового диапазона со встроенным источником света, основанный на линии передачи с полупроводниковой подложкой

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
CA2165826A1 (en) * 1993-07-01 1995-01-12 Alain E. Lagarde Hyaluronic acid fragments and their therapeutic use
US20110207666A1 (en) * 1996-03-05 2011-08-25 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
CN1157191C (zh) 1998-11-10 2004-07-14 电气化学工业株式会社 透明质酸凝胶、其制造方法及含透明质酸凝胶的医用材料
FR2811671B1 (fr) * 2000-07-17 2003-02-28 Corneal Ind Hydrogel de polymere(s), resistant a la biodegration, preparation et utilisation a titre de support de regeneration tissulaire
JP2005530768A (ja) * 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
ITMI20051230A1 (it) * 2005-06-29 2006-12-30 Pharmaperoducts Uk Ltd Composizioni farmaceutiche e cosmetiche contenenti colostro tocoferoli ossido di zinco e acido ialuronico
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
AU2008210557B2 (en) * 2007-01-30 2013-08-01 Cypress Pharmaceutical, Inc. Hyaluronate compositions
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IN163192B (ko) * 1983-10-11 1988-08-20 Fidia Spa
JPS60251898A (ja) * 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US5133755A (en) * 1986-01-28 1992-07-28 Thm Biomedical, Inc. Method and apparatus for diodegradable, osteogenic, bone graft substitute device
JPH072117B2 (ja) * 1986-10-09 1995-01-18 三菱レイヨン株式会社 ヒアルロン酸の製造法
US5041138A (en) * 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
US5180808A (en) * 1989-11-27 1993-01-19 La Jolla Cancer Research Foundation Versican core protein, nucleic acid sequences encoding the same, nucleic acid probes, anti-versican antibodies, and methods of detecting the same
EP0550638A4 (en) * 1990-09-25 1993-12-08 Smithkline Beecham Corporation Medium for culture of mammalian cells
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2721303C1 (ru) * 2019-12-03 2020-05-18 Самсунг Электроникс Ко., Лтд. Оптически-управляемый переключатель миллиметрового диапазона со встроенным источником света, основанный на линии передачи с полупроводниковой подложкой

Also Published As

Publication number Publication date
KR930702995A (ko) 1993-11-29
DE69127459T2 (de) 1998-01-02
ATE157253T1 (de) 1997-09-15
EP0560845B1 (en) 1997-08-27
WO1992010195A1 (en) 1992-06-25
KR100206314B1 (ko) 1999-07-01
CA2097181A1 (en) 1992-06-07
AU649092B2 (en) 1994-05-12
JPH06503319A (ja) 1994-04-14
AU9040991A (en) 1992-07-08
US5432167A (en) 1995-07-11
EP0560845A1 (en) 1993-09-22
DE69127459D1 (de) 1997-10-02
SE9003887L (sv) 1992-06-07

Similar Documents

Publication Publication Date Title
Sherman et al. Maggot therapy for treating pressure ulcers in spinal cord injury patients
US5929050A (en) Chondroitin sulfate composition and method for wound treatment
SE501217C2 (sv) Cellproliferationsmatris och användning därav
CA1254510A (en) Fibronectin preparations
CA2312558C (en) Collagen containing tissue adhesive
KR100268660B1 (ko) 간질성방광염의치료및예방을위한제약학적조성물
DE69634430T2 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
EP1317261B1 (en) Preparation for treating diseases of bone tissues comprising hydroxyapatite
CN108452293A (zh) 一种妇科用凝胶及其制备方法
Ofiaeli Complications of methods of fracture treatment used by traditional healers: a report of three cases necessitating amputation at Ihiala, Nigeria
CN1302813C (zh) 含海藻糖和透明质酸的烧伤用药传递系统及其制备方法
Eldad, A., Stark, M., Anais, D., Golan, J. & Ben-Hur Amniotic membranes as a biological dressing
EP1282429B1 (en) Pharmaceutical gel composition
US6156349A (en) Method of treating HIV infection with suppository containing mammalian liver extract
JPS58103324A (ja) インタ−フエロン組成物及びヘルペス感染症の治療における該組成物の使用
LIVINGSTON Local sulfonamide therapy in acute mastoiditis
Zimmerman et al. Clindamycin unresponsive anaerobic osteomyelitis treated with oral metronidazole
Gupta Efficacy of miconazole in experimental keratomycosis
RU2018309C1 (ru) Средство для лечения ложных суставов длинных трубчатых костей
Monami et al. Use of an oxidized regenerated cellulose and collagen composite for healing of chronic diabetic foot ulcers
Buchman et al. Precautionary administration of penicillin in surgical procedures on bones and joints
Wagh et al. Fundamentals of Jalaukavacharan (Leech therapy) and its importance in clinical practice: A review article
RU2123854C1 (ru) Средство для лечения инфекционных заболеваний дыхательных путей
RU2128975C1 (ru) Глазные капли "баларпан"
JPH08325143A (ja) 角膜実質損傷治療剤